Home › Funds › Jupiter Research Capital (Asia) Ltd › MRNA
Jupiter Research Capital (Asia) Ltd position in MRNA
MODERNA INC · Health Care
Jupiter Research Capital (Asia) Ltd reported holding 74,918 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$14.4M, representing 1.59% of its reported portfolio and ranking #7 among its reported holdings. Jupiter Research Capital (Asia) Ltd has disclosed MRNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
How Jupiter Research Capital (Asia) Ltd's MRNA position evolved
Jupiter Research Capital (Asia) Ltd first disclosed a stake in MRNA in Q1 2026 at 216,889 shares (US$11.0M). The position peaked in Q3 2026 at 74,918 shares, worth US$14.4M. Across 2 filings, Jupiter Research Capital (Asia) Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 74,918 shares valued at US$14.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 216.89K | $11.02M | New |
| Q3 2026 | 74.92K | $14.43M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 47 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Capital World Investors (US$4.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Fidelity Management & Research (FMR) 58.96M sh · $11.35B · Q3 2026
- Capital World Investors 22.64M sh · $4.36B · Q3 2026
- Capital World Investors 22.64M sh · $4.36B · Q3 2026
- Baillie Gifford & Co 11.44M sh · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M sh · $1.28B · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $892.01M · Q3 2026
- IMC-Chicago, LLC 3.07M sh · $590.92M · Q3 2026
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.42M sh · $466.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- a16z Perennial Management, L.P. 1.52M sh · $292.57M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.40M sh · $269.60M · Q3 2026
More on Jupiter Research Capital (Asia) Ltd
FAQ
How long has Jupiter Research Capital (Asia) Ltd held MRNA?
Jupiter Research Capital (Asia) Ltd has disclosed MRNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Jupiter Research Capital (Asia) Ltd's current position in MRNA?
As of Q3 2026, Jupiter Research Capital (Asia) Ltd holds 74.92K shares of MRNA (MODERNA INC), valued at $14.43M, representing 1.59% of its reported portfolio and ranking #7.
Has Jupiter Research Capital (Asia) Ltd been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Jupiter Research Capital (Asia) Ltd newly opened its position in MRNA. The position peaked in Q3 2026 at 74.92K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.